Meldonium injection solutions 10% 5ml/10pcs

$35.00

Diseases of the heart and vascular system, acute and chronic ischemic disorders of cerebral circulation..

Free International Shipping

Description

Meldonium indications

– complex treatment of coronary heart disease (angina, myocardial infarction, congestive heart failure and cardiomyopathy dishormonal);

– acute and chronic circulatory disorders of the brain (brain stroke and chronic cerebrovascular insufficiency);

– hemophthalmus and hemorrhages in the retina of different etiology, thrombosis, central retinal vein and its branches, retinopathy of different etiology (diabetic, hypertension);

– reduced performance, physical overload;

– withdrawal syndrome in chronic alcoholism (in combination with specific alcoholism therapy).

 

Contraindications

Hypersensitivity to the drug, increased intracranial pressure (in violation of the venous outflow, with intracranial tumors), organic central nervous system (CNS). Children age.

 

Dosage & Administration

Ways of administration – intravenous and parabulbarno.

Cardiovascular disease.

In the complex treatment of 0.5-1 g per day (5.10 ml solution for injection 0.5 g / 5 ml) using the entire dose at once or dividing it into 2 times. The course of treatment – 4-6 weeks.

Cerebrovascular accident.

Acute phase – 0.5 1 g once a day intravenously for 10 days, later moving to the reception inside. The total course of treatment – 4-6 weeks.

Chronic abuse – used oral dosage form.

Possible repeated courses (usually 2-3 times a year).

Vascular pathology and degenerative diseases of the retina.

Parabulbarno 0.5 ml solution for injection 0.5 g / 5 ml for 10 days.

Mental and physical overload.

0.5 g intravenously 1 per day. The course of treatment – 10-14 days. If necessary, repeat the treatment after 2-3 weeks.

Chronic alcoholism.

Intravenously 0.5 g 2 times a day. The course of treatment – 7-10 days.

Adverse reactions.

Since the cardiovascular system: rarely – tachycardia, arrhythmias, changes in blood pressure.

From hemopoiesis system: eosinophilia.

Central nervous system: rarely – headache, dizziness, psychomotor disturbances, paresthesia, tremor, agitation.